Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.CA) Reports Year Ended 31/12/2023 Consolidated Results
Company Name : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2023 To 31/12/2023
Net Profit : 253,205,908
F/S Consolidated Period : From 01/01/2022 To 31/12/2022
Net Comparative Profit : 252,887,775
Audit Status : Audited
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The ESG Report (647 KB)
The TCFD Report (311 KB)
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2023 To 31/12/2023
Net Profit : 253,205,908
F/S Consolidated Period : From 01/01/2022 To 31/12/2022
Net Comparative Profit : 252,887,775
Audit Status : Audited
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The ESG Report (647 KB)
The TCFD Report (311 KB)
Comments